Quantcast

Latest Lisinopril Stories

2014-09-08 08:29:26

--Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection-- NEW YORK, Sept. 8, 2014 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first clinical-stage drug development company based on open innovation, today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive...

2013-07-31 23:33:35

AffordRx.com now offering a Lisinopril discount card. Houston, TX (PRWEB) July 31, 2013 Hypertension, also referred to as high blood pressure, is a serious medical condition. In the United States, it causes over 200,000 deaths each year, according to the CDC. It affects more than one-third of Americans and is the main cause of early mortality in roughly nine percent of people. The good news is that modern medications can mitigate these factors and reduce the number of early deaths by...

2012-07-19 23:00:54

Natural Health Sherpa reviewed several studies and found out that hibiscus tea can help lower blood pressure. Wilmington, NC (PRWEB) July 19, 2012 Hibiscus tea lowers blood pressure, according to Natural Health Sherpa. The leading natural health website reviewed several studies on hibiscus and its effects on hypertension and found that there´s enough evidence to show that hibiscus is indeed effective in treating hypertension. A study published in the Phytomedicine compared the effects...

2011-12-07 14:36:01

One study presented at the meeting, which is being held in Budapest, Hungary, 7 to 10 December, reports on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin ®)´, while the other uses echocardiography to evaluate the protective role of ACE inhibitors and statins on the hearts of cancer patients². "These studies open the way for the early identification of myocardial damage at the subclinical level, thereby...

2011-08-16 07:00:00

SAN FRANCISCO, Aug. 16, 2011 /PRNewswire/ -- Practice Fusion's Research Division released today the second annual Prescription Index of the 20 most commonly prescribed medications by specialty among physicians using the company's Electronic Medical Record (EMR) system. Topping the list are prescriptions for blood pressure (Lisinopril, Family Practice), cholesterol (Simvastatin, Internal Medicine), infection (Amoxicillin, Pediatrics) and depression (Trazodone, Psychiatry). Since the release...

2010-12-01 00:04:00

EAST HANOVER, N.J., Dec. 1, 2010 /PRNewswire/ -- With more than 170 presentations focused on its marketed and pipeline compounds at key oncology medical congresses in December, Novartis continues to demonstrate progress of its innovative research and development efforts, collaboration with the scientific community and commitment to patients with cancer and rare diseases(1,2). The American Society of Hematology (ASH) annual meeting in Orlando, FL (December 4-7) will feature 30 oral...

2010-08-20 13:50:34

Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), led by Paul Whelton, MB, MD, MSc, president and CEO of Loyola University Health System, examined the comparative value of different blood pressure-lowering medications. More than 33,000 patients with high blood pressure were randomly...

24b28e948cab6cdeed405b8bb1e0ba851
2010-08-13 08:52:20

New long-term data from landmark ALLHAT study Expensive brand-name medications to lower blood pressure are no better at preventing cardiovascular disease than older, generic diuretics, according to new long-term data from a landmark study. Paul Whelton, MB, MD, MSc, reported the results on Aug. 13 at the plenary session of the China Heart Congress and International Heart Forum in Beijing. Whelton is president and CEO of Loyola University Health System and chairman of the Antihypertensive and...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.